ICCC; Pathology; 2016; Standard Reference; 2018

I; Leukemia; 2.50; 4.82; 4.22 II; Lymphomas; 0.62; 1.46;0.70 III; Central Nervous System; 0.40; 2.38;0.54 IV;Neuroblastoma;0.06;0.82;0.08 V;Retinoblastoma;0.34;0.49;0.66 VI;Kidney Tumors;0.14;0.65;0.36 VII;Liver Tumors;0.11;0.19;0.16 VIII;Bone Tumors;0.26;0.56;0.36 IX;Sarcomas;0.28;0.77;0.26 X;Germ Cells Tumors (no-SNC);0.36;0.42;0.38 XI;Carcinomas and other epithelial neoplasms;0.03;0.17;0.12 XII;Non Specific Malignancies;0.12;0.09;0.04 ;TOTAL CONFIRMED CANCER;5.22;12.81;8.18

ICCC; Patología; 2016; Referencia estandarizada; 2018

I; Leucemias; 2.50; 4.82; 4.22 II; Linfomas; 0.62; 1.46;0.70 III; Sistema Nervioso Central; 0.40; 2.38;0.54 IV;Neuroblastoma;0.06;0.82;0.08 V;Retinoblastoma;0.34;0.49;0.66 VI;Tumores renales;0.14;0.65;0.36 VII;Tumores hepáticos;0.11;0.19;0.16 VIII;Tumores óseos;0.26;0.56;0.36 IX;Sarcomas;0.28;0.77;0.26 X;Tumor de células germinales (no-SNC);0.36;0.42;0.38 XI;Carcinomas y otros neoplasmas epiteliales;0.03;0.17;0.12 XII;Neoplasias malignas no específicas;0.12;0.09;0.04 ;Total de cáncer confirmados;5.22;12.81;8.18

Diagnosis; No(%); Inc*

1.1 Acute Lymphoblastic Leukemia; 2268(37.2);2.23 1.2 Acute Myeloid Leukemia; 341(5.6); 2.23 1.3 Acute Promyelocytic Leukemia; 78(1.3); 2.23 1.4 Other Leukemia; 61(1.0);2.23 II.1 Hodgkin Lymphoma; 509(8.4); 0.64 II.2 Non Hodgkin Lymphoma; 275(4.5); 0.64 II.3 Lymphoma, NOS;18(0.3); 0.64 III. T. Central Nervous System; 374(6.1); 0.32 IV. Neuroblastoma; 84(1.4); 0.07 V. Retinoblastoma; 495(8.1); 0.43 VI.1 Wilms Tumor; 199(3.3); 0.19 VI.2 Kidney Tumor, not Wilms;24(0.4);0.19 VII.1 Hepatoblastoma;113(1.09); 0.15 VII.2 Hepatocellular Carcinoma; 62(1.0); 0.15 VIII.1 Osteosarcoma; 220(306); 0.23 VIII.2 Ewing Sarcoma; 114(109); 0.23 IX.1 Rhabdomyosarcoma; 155(2.5); 0.21 IX.2 Sarcoma not RMS; 120(2.0); 0.21 X. Germinal Cells Tumor; 279(4.6);0.21 XI. Epithelial Carcinoma; 89(1.5);0.05 XII. Neoplasms NOS;64(1.1);0.10 XII. Other Cancer;30(10.5);0.10 XIII. Histiocytic Sarcoma;125(2.1);0.10

Diagnosis; No(%); Inc*

1.1 Leucemia Linfoblástica Aguda; 2268(37.2);2.23 1.2 Leucemia Mieloide Aguda; 341(5.6); 2.23 1.3 Leucemia Promielocítica Aguda; 78(1.3); 2.23 1.4 Otras leucemias; 61(1.0);2.23 II.1 Linfoma Hodgkin; 509(8.4); 0.64 II.2 Linfoma No Hodgkin; 275(4.5); 0.64 II.3 Linfoma, NOS;18(0.3); 0.64 III. T. Sistema Nervioso Central; 374(6.1); 0.32 IV. Neuroblastoma; 84(1.4); 0.07 V. Retinoblastoma; 495(8.1); 0.43 VI.1 Tumor de Wilms; 199(3.3); 0.19 VI.2 Tumor renal,not Wilms;24(0.4);0.19 VII.1 Hepatoblastoma;113(1.09); 0.15 VII.2 Carcinoma hepatocelular; 62(1.0); 0.15 VIII.1 Osteosarcoma; 220(306); 0.23 VIII.2 S. de Ewing; 114(109); 0.23 IX.1 Rabdomiosarcoma; 155(2.5); 0.21 IX.2 Sarcoma no RMS; 120(2.0); 0.21 X. Tumor de células germinales; 279(4.6);0.21 XI. Carcinomas y N epiteliales; 89(1.5);0.05 XII. Neoplasias, NOS;64(1.1);0.10 XII. Otro cáncer;30(10.5);0.10 XIII. Tumor histiocítico;125(2.1);0.10